NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£1
Sector
HEALTH
Published
06 Apr 2023
Delivery
not specified
Deadline
n/a

Concepts

Location

United Kingdom: Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points

Geochart for 1 buyers and 63 suppliers

1 buyer

50 suppliers

Description

NHS Framework Agreement for Branded Medicines - National Proprietary PharmaceuticalsOffer reference number: CM/PHR/22/5675CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

Lot Division

1 CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines – Lot 1

Lot 1 - CM/PHR/22/5675/01 … Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
2 CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – Lot 2

Lot 2 - CM/PHR/22/5675/02 … Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Award Detail

1 Mercury Pharmaceuticals (London)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-1
  • Value: £1
2 Bayer (Reading)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-2
  • Value: £1
3 Sandoz (Surrey)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-3
  • Value: £1
4 Pfizer (Kent)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-4
  • Value: £1
5 Accord (Devon)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-5
  • Value: £1
6 Otsuka Pharmaceuticals (Wexham)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-6
  • Value: £1
7 Morningside Pharmaeuticals (Northampton)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-7
  • Value: £1
8 Astellas Pharma (Addlestone)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-8
  • Value: £1
9 Ipsen (Slough)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-9
  • Value: £1
10 Mylan (Hatfield)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-10
  • Value: £1
11 Ferring Pharmaceuticals (West Drayton)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-11
  • Value: £1
12 Drugsrus (Northwood)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-12
  • Value: £1
13 Medac Pharma (Stirling)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-13
  • Value: £1
14 Janssen Cilag (Highwycombe)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-14
  • Value: £1
15 Day Lewis Medical (Croydon Surrey)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-15
  • Value: £1
16 Teva (Castleford)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-16
  • Value: £1
17 Pharmasure (Hertfordshire)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-17
  • Value: £1
18 Recordati Rare Diseases (Bracknell)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-18
  • Value: £1
19 Chiesi (Manchester)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-19
  • Value: £1
20 Aspen Pharmacare (Central London)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-20
  • Value: £1
21 Gedeon Richter (London)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-21
  • Value: £1
22 Nordic Pharma (Theale)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-22
  • Value: £1
23 Novartis Pharmaceuticals (London)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-23
  • Value: £1
24 Synchrony (Stevenage)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-24
  • Value: £1
25 Orifarm (Hertfordshire)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-25
  • Value: £1
26 Eli Lilly (Hants)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-26
  • Value: £1
27 CST Pharma (Walsall)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-27
  • Value: £1
28 Rovi Biotech (Croydon)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-28
  • Value: £1
29 Dexcel Pharma (Northamptonshire)
  • NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1
  • Reference: 010254-2023-29
  • Value: £1
30 Gerot Lannach (Ely)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-30
  • Value: £1
31 Aventis Pharma (Berkshire)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-31
  • Value: £1
32 Tillomed Laboratories (Luton)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-32
  • Value: £1
33 Sandoz (Surrey)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-33
  • Value: £1
34 Pfizer (Kent)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-34
  • Value: £1
35 Accord (Devon)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-35
  • Value: £1
36 Morningside Pharmaeuticals (Northampton)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-36
  • Value: £1
37 Wockhardt (Wrexham)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-37
  • Value: £1
38 Lupin Healthcare (Berkshire)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-38
  • Value: £1
39 Mylan (Hatfield)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-39
  • Value: £1
40 Neuraxpharm (Cardiff)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-40
  • Value: £1
41 Ridge Pharma (Reading)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-41
  • Value: £1
42 Ferring Pharmaceuticals (West Drayton)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-42
  • Value: £1
43 Drugsrus (Northwood)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-43
  • Value: £1
44 Kent Pharma (Kent)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-44
  • Value: £1
45 Martindale Pharma (Essex)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-45
  • Value: £1
46 Janssen Cilag (Highwycombe)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-46
  • Value: £1
47 Day Lewis Medical (Croydon Surrey)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-47
  • Value: £1
48 Zentiva Pharma (London)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-48
  • Value: £1
49 Glenmark Pharmaceuticals Europe (Watford)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-49
  • Value: £1
50 Pharmasure (Hertfordshire)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-50
  • Value: £1
51 Xiromed (Höllviken)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-51
  • Value: £1
52 Aspire Pharma (Surrey)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-52
  • Value: £1
53 Chiesi (Manchester)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-53
  • Value: £1
54 Selective Supplies (London)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-54
  • Value: £1
55 Napp Pharmaceuticals (Cambridge)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-55
  • Value: £1
56 Gedeon Richter (London)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-56
  • Value: £1
57 Norgine Pharmaceuticals (Middx)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-57
  • Value: £1
58 Qdem Pharmaceuticals (Cambridge)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-58
  • Value: £1
59 CST Pharma (Walsall)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-59
  • Value: £1
60 Merck Serono (Middlesex)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-60
  • Value: £1
61 Takeda (London)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-61
  • Value: £1
62 Tetris Pharma (Buckinghamshire)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-62
  • Value: £1
63 Theramex HQ (London)
  • Lot 2 - CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2
  • Reference: 010254-2023-63
  • Value: £1

Renewal Options

Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains